Conditions & Treatments
Learn from the Experts
Support Your Practice
Conferences & Highlights
Community Resources
Our Expert Network

CME & Education About Us

Loading...

CME & Education About Us

Loading profile...

Conditions & Treatments
Learn from the Experts
Support Your Practice
Conferences & Highlights
Community Resources
Our Expert Network

The leading solutions platform for dermatology professionals to elevate patient care.

Helpful Links

Terms of Service

Editorial & Medical Review Policy

Privacy Policy

Cookie Policy

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2026 dermsquared | All Rights Reserved

What results were seen in the 2-year open-label extension for ruxolitinib for vitiligo?

Results 2 Year Open Label Extension Ruxolitinib Vitiligo

#top-leaderboard-ads, .stickyads { position: static !important; }

What results were seen in the 2-year open-label extension for ruxolitinib for vitiligo?

Featuring David Rosmarin, MD | Vice Chair of Education and ResearchTufts Medical CenterBoston, MA | Published May 01, 2024

Loading...

Related CME

Related Media

Powered by Polaris ^TM

Loading...